Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway
10.1371/journal.pone.0020932
Saved in:
Main Authors: | Cheng C., Ho W.E., Goh F.Y., Guan S.P., Kong L.R., Lai W.-Q., Leung B.P., Wong W.S.F. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
Public Library of Science (PLoS)
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/141964 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Anti-malarial drug artesunate ameliorates oxidative lung damage in experimental allergic asthma
by: Ho, W.E., et al.
Published: (2014) -
An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model
by: Duan, W., et al.
Published: (2012) -
The role of sphingosine kinase in a murine model of allergic asthma
by: Lai, W.-Q., et al.
Published: (2011) -
INVESTIGATIONS OF ANTI-INFLAMMATORY MECHANISMS OF ANTI-MALARIAL DRUG ARTESUNATE IN ALLERGIC ASTHMA
by: HO WANXING EUGENE
Published: (2014) -
Role of protein kinase C and phosphoinositide 3-kinase-Akt in substance P-induced proinflammatory pathways in mouse macrophages
by: Sun, J., et al.
Published: (2011)